Torres J, Bonovas S, Doherty G et al (2020) ECCO guidelines on therapeutics in crohns disease: medical treatment
Zeng FG, Richardson M, Tran P, Lin H, Djalilian H
The TRIUMPH-Outcomes trial will be the most important dataset for resolving remaining questions
Understanding your genetic predispositions helps your provider personalize not only your tirzepatide dose but also your entire pain management strategy
Factores relacionados con la adherencia: Efectos adversos gastrointestinales : Nuseas, vmitos, diarrea y estreimiento son los efectos secundarios ms comunes, reportados en aproximadamente 44%, 24%, 23% y 22% de los pacientes respectivamente, segn el etiquetado de Wegovy